Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of oligomeric hyaluronic acid or its salt in the preparation of medicine for treating myocardial infarction

A technology of oligomeric hyaluronic acid and hyaluronic acid, which is applied in the direction of drug combination, pharmaceutical formula, cardiovascular system diseases, etc., can solve the problems such as no reports of oligomeric hyaluronic acid myocardial infarction, and achieve good clinical application prospects, Effect of increasing the number of myocardial blood vessels and promoting survival

Active Publication Date: 2021-01-22
WEST CHINA HOSPITAL SICHUAN UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] There is no report on the treatment of myocardial infarction with oligomeric hyaluronic acid and its salts

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of oligomeric hyaluronic acid or its salt in the preparation of medicine for treating myocardial infarction
  • Application of oligomeric hyaluronic acid or its salt in the preparation of medicine for treating myocardial infarction
  • Application of oligomeric hyaluronic acid or its salt in the preparation of medicine for treating myocardial infarction

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] Embodiment 1 Preparation of oligomeric hyaluronic acid of the present invention

[0028] Dissolve 100 mg of h-HA with a molecular weight of 1 million in 50 mL of 0.1 M sodium acetate buffer (pH 5.4), add 20,000 activity units of bovine testicular hyaluronidase, and incubate at 37°C for 8 hours. 10 mL of the solution was removed and 1 mL of 100% trifluoroacetic acid (TCA) was added to neutralize the hyaluronidase. The resulting enzyme precipitate was removed by centrifugation. The supernatant was collected and dialyzed in a dialysis bag with a molecular weight of 1000 Da at 4°C for 72 hours, and the water was changed at least 6 times in the middle. The liquid in the dialysis bag was collected, and the dialysis was continued for 72 hours at 4° C. in a dialysis bag with a molecular weight of 5000 Da. After the dialysis, the outer aqueous phase was collected and freeze-dried, and the freeze-dried o-HA sample was stored at 4°C for future use.

[0029] The molecular weight...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
number average molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention discloses a use of HA-Oligo or salt of HA-Oligo in preparation of medicines for treating miocardial infarction. The HA-Oligo and salt of HA-Oligo disclosed by the invention can effectively treat the miocardial infarction and is significant in treatment effects, a new medicine for clinical treatment of the miocardial infarction is provided, and the clinical application prospects are good.

Description

technical field [0001] The present invention relates to the application of oligomeric hyaluronic acid or its salt in the preparation of medicine for treating myocardial infarction. Background technique [0002] Myocardial infarction, also known as myocardial infarction, refers to myocardial necrosis caused by acute and persistent ischemia and hypoxia (coronary insufficiency); refers to the interruption of coronary blood on the basis of coronary artery disease, causing the corresponding myocardial Severe and persistent acute ischemia will eventually lead to ischemic necrosis of the myocardium; patients with acute myocardial infarction often have persistent severe retrosternal pain, fever, increased white blood cell count, elevated serum myocardial enzymes, and electrocardiogram Reflects a series of characteristic evolutions of acute myocardial injury, ischemia and necrosis, and may appear arrhythmia, shock and heart failure, is a severe type of coronary heart disease, may be ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/728A61P9/10
CPCA61K31/728A61P9/10
Inventor 巩长旸吴秦洁王宁
Owner WEST CHINA HOSPITAL SICHUAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com